Yahoo Finance • 18 days ago
Cardinal Health, Inc. (NYSE:CAH) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts.Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2 Morgan Stanley boosted its price recommendation... Full story
Yahoo Finance • 22 days ago
Feb 5 (Reuters) - Cardinal Health on Thursday raised its expectations for annual profit after surpassing Wall Street estimates for quarterly results, as it bets on robust demand for specialty medicines and strong performance across its s... Full story
Yahoo Finance • 23 days ago
The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -0.51%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.53%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.77%. March E-mini S&P futures (ESH26) fell -0.44%, and M... Full story
Yahoo Finance • 23 days ago
The S&P 500 Index ($SPX) (SPY) today is down -0.11%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.69%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.05%. March E-mini S&P futures (ESH26) are down -0.16%, and March E-mini Nas... Full story
Yahoo Finance • 23 days ago
Earnings Call Insights: Cencora, Inc. (COR) Q1 2026 MANAGEMENT VIEW * CEO Robert Mauch announced the completion of the acquisition of the majority of the remaining equity interest in OneOncology, emphasizing, "we are raising our fiscal... Full story
Yahoo Finance • 23 days ago
The S&P 500 Index ($SPX) (SPY) today is up +0.08%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.54%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.56%. March E-mini S&P futures (ESH26) are up +0.08%, and March E-mini Nasdaq... Full story
Yahoo Finance • 23 days ago
(RTTNews) - Cencora, Inc. (COR) revealed a profit for its first quarter that Increases, from the same period last year The company's bottom line came in at $559.64 million, or $2.87 per share. This compares with $488.60 million, or $2.50... Full story
Yahoo Finance • 2 months ago
Last week, major U.S. indexes ended the Christmas-shortened week higher, with the S&P 500 and the Dow attaining new record highs. The S&P 500, the Dow Jones Industrial Average and the tech-heavy Nasdaq Composite gained 0.75%, 0.72% and 0.7... Full story
Yahoo Finance • 2 months ago
Glaukos Corporation GKOS is well-poised for growth on the back of the iDose TR launch and a robust product pipeline. However, stiff competition is a concern. Shares of this Zacks Rank #3 (Hold) company have gained 12.5% so far this year c... Full story
Yahoo Finance • 2 months ago
Health care stocks rose late Monday afternoon with the NYSE Health Care Index gaining 1.2% and the S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 2 months ago
Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.9% and the State Stre PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 2 months ago
Cencora (COR) said Monday that it agreed to acquire majority of the stake it doesn't already own in PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story
Yahoo Finance • 3 months ago
Wall Street's major averages closed in the green on Friday, as traders assessed fresh inflation data in hopes of gauging the Federal Reserve's monetary policy. The benchmark S&P 500 closed +0.2%, while the Nasdaq Composite ended +0.3%, an... Full story
Yahoo Finance • 3 months ago
Cencora, Inc. (NYSE:COR) is included among the 15 Dividend Stocks that Outperform the S&P 500.JPMorgan Raises Cencora (COR) Price Target After Financial Model Update Photo by Dan Dennis on Unsplash On November 11, JPMorgan raised its p... Full story
Yahoo Finance • 3 months ago
Expanded capabilities in Europe and the United States enable company to deliver enhanced third-party logistics support to pharmaceutical companies CONSHOHOCKEN, Pa., December 03, 2025--(BUSINESS WIRE)--Cencora, a global pharmaceutical sol... Full story
Yahoo Finance • 3 months ago
Below is Validea's guru fundamental report for CENCORA INC (COR). Of the 22 guru strategies we follow, COR rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks... Full story
Yahoo Finance • 3 months ago
Below is Validea's guru fundamental report for CENCORA INC (COR). Of the 22 guru strategies we follow, COR rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks... Full story
Yahoo Finance • 4 months ago
This article first appeared on GuruFocus. Release Date: November 05, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Cencora Inc (NYSE:COR) reported a 16% growth... Full story
Yahoo Finance • 4 months ago
By Padmanabhan Ananthan (Reuters) -Cencora will invest over $1 billion through 2030 to expand its U.S. network, the drug distributor said on Wednesday, after forecasting adjusted profit for next year above Wall Street expectations. The c... Full story
Yahoo Finance • 4 months ago
[Pharmaceutical.] artisteer/iStock via Getty Images Drug distributor Cencora (COR [https://seekingalpha.com/symbol/COR]) is looking to invest $1B through 2030 to strengthen its U.S. supply chain, the company said on Wednesday as it report... Full story